# Random Trial for Elderly Patients With NSCLC

> **NCT00265694** · PHASE3 · UNKNOWN · sponsor: **Inje University**

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** vinorelbine, gemcitabine and carboplatin

## Key facts

- **NCT ID:** NCT00265694
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265694, "Random Trial for Elderly Patients With NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00265694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*